Longevity Health Holdings, Inc.

Longevity Health Holdings, Inc. is a bio-aesthetics company that develops, manufactures, and markets cosmetic skincare and haircare products. The company uses Carmell Secretome and Elevai Exosomes to support skin and hair health. Carmell Secretome is composed of growth factors, proteins, and peptides derived from allogeneic human platelets. Elevai Exosomes contain growth factors, cytokines, peptides, and other small molecules that play a role in the body's natural healing processes. Longevity Health Holdings, Inc. also develops a microemulsion formulation designed to deliver both lipophilic and hydrophilic ingredients. This formulation avoids the use of the "Foul Fourteen," which are 14 potentially harmful excipients often used by other companies to achieve desired texture, stability, and other physical and chemical properties in cosmetic products. The company holds a licensing agreement with Carnegie Mellon University for the development and commercialization of biocompatible plasma-based plastics. Founded in 2008, the company was previously known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Its headquarters are located in Pittsburgh, Pennsylvania.